Nigerian Pharma Stocks Surge in 2025, Fidson and Neimeth Lead Gains
Nigerian pharmaceutical companies have emerged as top performers in 2025, with stocks like Fidson Healthcare and Neimeth International Pharmaceuticals delivering impressive returns on the Nigerian Exchange. Fidson Healthcare saw a 177% gain, while Neimeth International Pharmaceuticals recorded a 169% increase.
These gains reflect growing investor confidence in the healthcare sector amidst economic pressures. The market capitalization of these companies has significantly increased, positioning them as valuable players in Nigeria's equity market.
Plus234Feed summary based on reporting from Business Day. Read the original report below.
Read full article
Continue on Business Day
Get the week in one email
Top stories, NPFL results, the naira — every Friday morning. Free, one email a week.
Related Stories
Nigerian Pharma Stocks Create Millionaires in 2025 Amid Industry Transformation
Nigerian Stock Market: Top 40 Stocks Deliver 100% Returns in 2025
Fidson Achieves Strongest Performance in Three Years in 2025
Fidson Reports 61% Profit Surge Amid Prescription Drug Boom
Top 10 Best-Performing Unlisted Equities in Nigeria for 2025 Revealed
Nigeria's Consumer Goods Stocks Drive Historic Rally on NGX in 2025
Get Plus234Feed on messaging apps
Same headlines, delivered where you already scroll.
